Cleared Traditional

K903237 - CARDIOCAP CMX-104 MONITOR

K903237 is an FDA 510(k) clearance for CARDIOCAP CMX-104 MONITOR, manufactured by Datex Division Instrumentarium Corp.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 359-day FDA review.

K903237 · Datex Division Instrumentarium Corp. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1991
Decision
359d
Days
Class 2
Risk

K903237 is an FDA 510(k) clearance for the CARDIOCAP CMX-104 MONITOR. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Datex Division Instrumentarium Corp. (Helsinki, Finland, FI). The FDA issued a Cleared decision on July 17, 1991 after a review of 359 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Datex Division Instrumentarium Corp. devices

FDA 510(k) Submission Details - K903237

510(k) Number K903237 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 1990
Decision Date July 17, 1991
Days to Decision 359 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
234d slower than avg
Panel avg: 125d · This submission: 359d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 647
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K903237.
DIGITAL SPHYGMOIMANOMETER, MODEL UA-830
K911049 · A&D Engineering, Inc. · Aug 1991
DIGITAL SPHYGMOMANOMETER MODEL UA-833
K912118 · A&D Engineering, Inc. · Aug 1991
DIGITAL SPHYGMOMANOMETER MODEL UB-211 AND 212
K912119 · A&D Engineering, Inc. · Aug 1991
COROMETRICS 5566AAX NONINVASIVE BLOOD PRESSURE MOD
K911310 · Ge Medical Systems Information Technologies · Jun 1991
E-20 RAPID CUFF INFLATOR
K905367 · D. E. Hokanson, Inc. · Mar 1991
HP MODEL M1008B, NONINVASIVE BLOOD PRESSURE MODULE
K903771 · Hewlett-Packard Co. · Feb 1991